Реферат RUS  Реферат ENG  Литература  Полный текст
УДК:617.741

Dexamethasone impact on vimentin in human lens epithelial cells


1----------

    Paper highlights: As a result of the GIC single factor influence, making its drug treatment with clear goals, if we can further understand the pathogenesis of GIC, research and development a target design drugs can prevent the happening of the GIC.

    Foundation item: Thanks very much for the National Natural Science Foundation of China (30973275) and Specialized Research Fund for the Doctoral Program of Higher Education (20112307110013).

    

     Long-term systemic or local application of corticosteroids can cause the posterior subcapsular opacities (PSO), known as glucocorticoid induced cataract (GIC). Related to the pathogenesis of GIC, there are many hypotheses, but none of them can explain the formation of PSO, so there is no effective means in the prevention and treatment. New view thought that hormones may through its receptor mediated vimentin changes to affect lens epithelial cell proliferation and differentiation, eventually leading to the formation of GIC. Therefore, to study the influence of vimentin impact on lens epithelial cell proliferation and differentiation may be a new direction for research in the pathogenesis of GIC. We proposed by dexamethasone (Dex) impact on the human lens epithelial cells (HLECs), to investigate the influence of the expression of vimentin protein changes and discussed which in the mechanism of GIC, especially the formation of the PSO.

    Material and methods

    1.1. Material

    HLECs purchased from the American Cell Bank (ATCC), fetal bovine serum FBS (U.S. Gibco), Dex (U.S. Sigma), reverse transcription kit (United States Life), real-time PCR kit (United States Life), QPCR instrument (American Life). Mouse anti-human vimentin IgG (USA Santa Cruz), rabbit anti-mouse IgG (USA Santa Cruz), SDS-PAGE gel kit (Pik days Reagent Company), microplate reader (US Bio Rad), EVOS inverted fluorescence microscope (USA AMG), gel imager act.

    1.2. Methods

    1.2.1. HLECs vitro

    HLECs cultured in DMEM medium containing 20% fetal bovine serum, 100 U ml / 1 penicillin, 0.1 mg ml / 1 streptomycin and 2μ M L- glutamine. They were divided into two groups: the hormone group (Dex Group): DMEM + 1umol / L, Dex, the control group (Control Group): DMEM + 0umol / LDex.

    1.2.2. Analysis of vimentin mRNA by Real-time PCR

    Total cellular RNA extraction and real-time PCR reactions carried out in accordance with classical methods previously [1]. The upstream primer of vimentin was 5’-ACCGCTTTGCCAACTACAT-3’, the Under primeris was 5’-GTCCCGCTCCACCTC-3’.

    1.2.3. Analysis of vimentin by western blotting

    (1) Extraction of total cellular proteins: Digestion of each group cells to extract total proteins of cells.

    (2) Westren-blot: Taking protein samples to take SDA-PAGE gel electrophoresis, transferred to a membrane to wet nitrocellulose membrane (NC film), the NC membrane placed in blocking buffer overnight at 4° C. They were then incubated overnight at 4° C with the primary vimentin antibody(mouse anti-human vimentin antibody and mouse anti-human GAPDH antibody, 1:1000). After washing five times with TBST, membranes were incubated for 2 h with Rabbit anti-mouse secondary antibodies(Rabbit anti-mouse IgG, 1:1000). Images were detected with the Alkaline phosphatase color kit. The scanned images were quantified using Gel documentation system.

    1.2.4. Immunofluorescence staining analysis for vimentin

    The cells were passaged to confocal dish, cultured for 12h after washing twice with PBS, each time 10min. They were joined 4% paraformaldehyde solution to fixed 15-20min at room temperature, then washing 3 times with PBS; joined 0.2% Troton X-100 to permeabilize cell 7min, then joined 4% BSA to block 1h they were then incubated overnight with the primary vimentin antibody (mouse anti-human vimentin antibody) 1:400. After washing three times with PBS, they were incubated for 30 min with fluorescent secondary antibodies 1:400 at room temperature from light. Washing three times with PBS, then were observed under fluorescent microscope.

    1.2.5. Image Acquisition and Analysis

    The results of Real-time PCR detected by Quantity One program statistics, obtaining CT value of each set of PCR, using the calculation method of gene expression Ct strength. The images of Western-blot were measured by the Image J program to strip the central density.

    1.3. Statistical methods

    Using SPSS19.0 statistical software for statistical analysis. All the experiments were repeated three times, all data as x±s, groups were compared using ANOVA, with p<0.05 was considered statistically significant.

    Results

    2.2.1. The results of Real-time PCR and Western-blot

    HLECs after Dex induced 7d, Vimentin mRNA expression is reduced, the significant difference between groups (p<0.05) (figure 1a). HLECs after Dex induced 7d, Vimentin protein expression was significantly decreased, the significant difference between groups (p<0.05). GAPDH express was no statistically significant difference between groups (p>0.05) (figure 1b).

    2.2.2 The results of Immunofluorescence staining

    Vimentin expression in the cytoplasm in the HLECs, nuclear weeks radiating interwoven into a network structure to the peripheral connected to the cell membrane, distribution range and cell shape contour (figure 2). The control group vimentin fiber bundle of thick, dense, dense mesh structure, suggests the expression of vimentin is high (frgure 2a). Dex group of vimentin fiber bundle sparse, slender, sparse mesh structure, suggests that the expression of vimentin is low (figure 2b), consistent with the results of western-blot.

    Discussion

    Glucocorticoid induced cataract (GIC) is the main complications in the eye of the application of hormone [10]. Epidemiological and clinical observations have been confirmed, systemic, topical corticosteroids and inhaled corticosteroid therapy are likely to cause cataracts [2]. There were many hypotheses about GIC formation mechanism [11]. Studies have shown that changes in GR-mediated vimentin could direct impact on the shape and function of lens cells, which in turn leads to the formation of GIC.

    Typical performance of GIC was PSO. The main morphological changes were [6]: posterior subcapsular opacities cortical, lesions tend to be clearer boundary, that the whole appearance was granular gravel. Histological changes characteristic were [5]: anterior lens capsule, the front cortex and nucleus - relatively normal, the posterior pole of lens fiber cell swelling, disorganized nuclear elongation, posterior subcapsular cortex lesions visible in varying degrees round.

    Vimentin as an important cytoskeletal protein, which is expressed in an appropriate amount of lens cells, is important to maintain normal morphology and function [12]. Recent studies have shown that the expression of vimentin was related to glucocorticoid receptors [1]. But, the exact role of vimentin in biology within the lens is unknown.

    Hong Yan first reports to demonstrate that dexamethasone can reduce the expression of vimentin in rats lens epithelial cells [9]. Our study shows that dexamethasone can significantly reduce the expression of vimentin in HLECs, which indicates GR involved the change of human lens vimentin expression levels. This is the first report showed that, Dex inducing of cataract was related to the decreased expression of vimentin. Previous studies have also confirmed that vimentin was involved of lens epithelial cell signal transduction, structural changes in cells, and cell differentiation and apoptosis [4]. It can be presumed that the reduction of expression of vimentin in HLECS caused by Dex could affect the structure and function of lens epithelial cells, thereby leading to changes in lens transparency [13].

    Glucocorticoid treatment of human lens epithelial cells results in activation of the GR and subsequent modulation of target gene expression via the mitogen activated protein kinases (MAPKs) and phosphatidylinositol 3 kinase/protein kinase B (PI3K)/AKT) pathways [3, 14]. And then likely to affect many cellular functions, such as proliferation, differentiation, apoptosis, survival, or migration. All of these are possible related to the formation of GIC. It is also interesting to note that involvement of both the PI3K/AKT and MAPK pathways has been reported for vimentin expression and activity [6]. Our studies have shown that Dex can induce HLECs in decreased expression of vimentin. Our studies already proved that Dex can induce expression of vimentin in HLECs, which may cause abnormal lens epithelial cell proliferation and differentiation, eventually leading to the formation of GIC.

    In summary, this study has proved in the gene level, protein level and in terms of morphology and distribution of proof that Dex can induce human lens epithelial cells vimentin content decreased. Which could speculate that the possible mechanism of Dex inducing GIC maybe by inducing reduce GR-mediated vimentin content, resulting in abnormal lens epithelial cell differentiation, signal transduction, survival and apoptosis, ultimately inducing the formation of GIC. Future experiments will a further study the relationship between the expression of vimentin protein with the changes of hormone concentrations, and further study the specific pathogenesis of GIC, in order to research the GIC prevention and drug treatment targets.

    

    Received 15.10.2015

    

    Information about the authors:

    Ping Liu, Male, Medical Doctor

    Eye Hospital, the First Affiliated Hospital of Harbin Medical University, Harbin (China)


Страница источника: 13

Федоровские чтения - 2017 Сателлитные симпозиумы в рамках XIV Всероссийской научно-практической конференцииФедоровские чтения - 2017 Сателлитные симпозиумы в рамках XI...

Восток – Запад 2017 Международная научно-практическая конференция по офтальмологииВосток – Запад 2017 Международная научно-практическая конфер...

Белые ночи - 2017 Сателлитные симпозиумы в рамках Международного офтальмологического конгресса Белые ночи - 2017 Сателлитные симпозиумы в рамках Международ...

Новые технологии в контактной коррекции.  В рамках  Всероссийской научно-практической конференции «Новые технологии в офтальмологии - 2017»Новые технологии в контактной коррекции. В рамках Всеросси...

Новые технологии в офтальмологии -  2017 Всероссийская научно-практическая конференция Новые технологии в офтальмологии - 2017 Всероссийская научн...

XVI Всероссийская школа офтальмологаXVI Всероссийская школа офтальмолога

Сателлитные симпозиумы в рамках конференции «Современные технологии лечения витреоретинальной патологии - 2017»Сателлитные симпозиумы в рамках конференции «Современные тех...

Современные технологии лечения витреоретинальной патологии - 2017 ХV Научно-практическая конференция с международным участиемСовременные технологии лечения витреоретинальной патологии -...

«Живая хирургия» в рамках конференции «Современные технологии лечения витреоретинальной патологии - 2017»«Живая хирургия» в рамках конференции «Современные технологи...

Роговица I. Ультрафиолетовый кросслинкинг роговицы в лечении кератоэктазий Научно-практическая конференция с международным участиемРоговица I. Ультрафиолетовый кросслинкинг роговицы в лечении...

Сателлитные симпозиумы в рамках ХIV ежегодного конгресса Российского глаукомного обществаСателлитные симпозиумы в рамках ХIV ежегодного конгресса Рос...

Сателлитные симпозиумы в рамках конференции Современные технологии катарактальной и рефракционной хирургии - 2016Сателлитные симпозиумы в рамках конференции Современные техн...

«Живая» хирургия в рамках конференции Современные технологии катарактальной и рефракционной хирургии - 2016«Живая» хирургия в рамках конференции Современные технологии...

Современные технологии катарактальной и рефракционной хирургии - 2016Современные технологии катарактальной и рефракционной хирург...

Сателлитные симпозиумы в рамках IX Российского общенационального офтальмологического форумаСателлитные симпозиумы в рамках IX Российского общенациональ...

На стыке науки и практикиНа стыке науки и практики

Федоровские чтения - 2016 XIII Всероссийская научно-практическая конференция с международным участиемФедоровские чтения - 2016 XIII Всероссийская научно-практиче...

Актуальные проблемы офтальмологии XI Всероссийская научная конференция молодых ученыхАктуальные проблемы офтальмологии XI Всероссийская научная к...

Восток – Запад 2016 Научно-практическая конференция по офтальмохирургии с международным участием Восток – Запад 2016 Научно-практическая конференция по офтал...

Белые ночи - 2016 Сателлитные симпозиумы в рамках Международного офтальмологического конгресса Белые ночи - 2016 Сателлитные симпозиумы в рамках Международ...

Невские горизонты - 2016 Научная конференция офтальмологовНевские горизонты - 2016 Научная конференция офтальмологов

Сателлитные симпозиумы в рамках научной конференции офтальмологов «Невские горизонты - 2016»Сателлитные симпозиумы в рамках научной конференции офтальмо...

Новые технологии в офтальмологии 2016 Всероссийская научно-практическая конференция Новые технологии в офтальмологии 2016 Всероссийская научно-п...

Витреоретинальная хирургия. Макулярный разрывВитреоретинальная хирургия. Макулярный разрыв

Современные технологии лечения витреоретинальной патологии - 2016 ХIV Научно-практическая конференция с международным участиемСовременные технологии лечения витреоретинальной патологии -...

Совет экспертов, посвященный обсуждению первого опыта использования новой офтальмологической системы CENTURION®Совет экспертов, посвященный обсуждению первого опыта исполь...

HRT/Spectralis* Клуб Россия 2015 – технология, ставшая незаменимой!HRT/Spectralis* Клуб Россия 2015 – технология, ставшая незам...

Три письма пациента. Доказанная эффективность леченияТри письма пациента. Доказанная эффективность лечения

Синдром «сухого» глаза: новые перспективыСиндром «сухого» глаза: новые перспективы

Многоликий синдром «сухого» глаза: как эффективно им управлять?Многоликий синдром «сухого» глаза: как эффективно им управлять?

Прошлое... Настоящее! Будущее?Прошлое... Настоящее! Будущее?

Проблемные вопросы глаукомы IV Международный симпозиумПроблемные вопросы глаукомы IV Международный симпозиум

Секундо В. Двухлетний личный опыт с линзами AT Lisa Tri и AT Lisa Tri ToricСекундо В. Двухлетний личный опыт с линзами AT Lisa Tri и AT...

Инновации компании «Алкон» в катарактальной и рефракционной хирургииИнновации компании «Алкон» в катарактальной и рефракционной ...

Применение устройств HOYA iSert Toric. Применение торических ИОЛ HOYA iSert Toric в рефракционной хирургии катарактыПрименение устройств HOYA iSert Toric. Применение торических...

Рейтинг@Mail.ru